Prevalence and relevance of EBV latency in nasopharyngeal carcinoma in Israel
Open Access
- 1 March 2004
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 57 (3), 290-293
- https://doi.org/10.1136/jcp.2003.013094
Abstract
Background: Nasopharyngeal carcinoma (NPC) is frequently associated with Epstein-Barr virus (EBV). The incidence of NPC in Western countries is lower than in the Far East, and EBV latency in NPC is less prevalent. Israel, as a part of the Mediterranean area, is one of the countries with an intermediate risk for NPC. Methods: Immunohistochemistry (IHC) for latent membrane protein 1 (LMP-1) and in situ hybridisation (ISH) for EBV encoded RNA (EBER) were used to evaluate the prevalence and possible prognostic value of EBV latency among Israeli patients with NPC. Forty five patients with different NPC histologies were studied. Results: LMP-1 IHC was positive in six samples only, all with undifferentiated histology. EBER ISH was positive in 40 of the 45 samples. According to histological type, three of five patients with squamous cell carcinoma were EBV positive and 37 of 40 non-keratinising and undifferentiated carcinoma cases were positive. Although EBV was more prevalent in patients with non-squamous carcinoma, the difference was not significant, probably because of the small number of patients with keratinising carcinoma. With regard to the clinical categories and survival, no significant difference could be detected between patients who were positive or negative for EBER ISH. No association was found between EBV latency and patient sex, age, origin, stage, or survival. Conclusions: NPC in Israel is highly associated with EBV latency as detected by EBER ISH. LMP-1 IHC is considerably less sensitive in detecting EBV latency in NPC among the same patient group.Keywords
This publication has 17 references indexed in Scilit:
- Expression of Epstein-Barr virus-encoded RNA and biological markers in Italian nasopharingeal carcinomas.2001
- Update on nasopharyngeal carcinoma in northern Israel.1994
- Nasopharyngeal cancer: epidemiology, staging, and treatment.1994
- Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinomaCancer, 1992
- Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens.1991
- Computed tomography in nasopharyngeal carcinoma: Part I: T-stage conversion with CT-stagingInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Epstein--Barr Virus Gene Expression in Nasopharyngeal CarcinomaJournal of General Virology, 1988
- Nospharyngeal carcinoma in Israel: Epidemiology and Epstein-Barr virus-related serologyEuropean Journal of Cancer and Clinical Oncology, 1987
- Carcinoma of the nasopharynx: An analysis of 91 cases and a comparison of differing treatment approachesCancer, 1986
- Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the NasopharynxNature, 1970